Compare STNG & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STNG | MMSI |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 2010 | 1996 |
| Metric | STNG | MMSI |
|---|---|---|
| Price | $83.68 | $86.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $83.33 | ★ $98.88 |
| AVG Volume (30 Days) | 622.6K | ★ 624.4K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 1.33 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $4.31 | $8.85 |
| Revenue Next Year | N/A | $5.88 |
| P/E Ratio | ★ $10.06 | $65.70 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $48.93 | $59.74 |
| 52 Week High | $87.39 | $94.75 |
| Indicator | STNG | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 63.66 | 47.34 |
| Support Level | $73.03 | $82.68 |
| Resistance Level | $87.39 | $89.73 |
| Average True Range (ATR) | 1.95 | 1.87 |
| MACD | 0.54 | -1.00 |
| Stochastic Oscillator | 99.37 | 7.29 |
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.